Extending storage time of donor lungs outside the body
Storing donor lungs for transplant at 10°C markedly increases the length of time the organ can live outside the body, according to a clinical trial led by University Health Network’s (UHN) Ajmera Transplant Centre, Canada. Results of the trial were published in NEJM Evidence.
Lungs available for transplant are currently limited by the length of time a donor organ can be kept viable. Increasing storage time allows for viable donor lungs to come from greater distances, increasing the potential for greater numbers of lungs becoming available for transplant and overcoming many of the hurdles around transplant logistics.
The multicentre, non-randomised clinical trial of 70 patients demonstrated that donor lungs stored at 10°C remained healthy and viable for transplant up to four times longer compared to storage at the current standard of ice cooler preservation of around 4°C. The trial took place over 18 months at UHN’s Toronto General Hospital, the Medical University of Vienna, and Hospital Universitario Puerta de Hierro-Majadahonda in Madrid.
Some advantages of a 10°C standard for lung storage include the potential to reduce or eliminate the 24/7 schedule and urgency of lung transplant procedures. By increasing the length of time donor lungs are viable, transplant surgeries could become planned procedures, which avoids bumping scheduled surgeries and overnight transplantation.
The study suggests the new preservation temperature will allow more time to optimise immunologic matching between donor and recipients, and the possibility of performing lung transplantation in a semi-elective rather than urgent fashion. Better organ preservation also means better outcomes for patients.
“The clinical impact of this study is huge,” said lead author Dr Marcelo Cypel, Surgical Director of the Ajmera Transplant Centre.
“It’s a paradigm shift for the practice of lung transplant.”
MV Hondius passengers return to Australia under strict infection control measures
The Australian CDC has provided an update on hantavirus risk to Australians and infection...
$96m RNA Research and Manufacturing Facility opens in NSW
The new 4500 sqm RNA Research and Manufacturing Facility within the Macquarie University...
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
